PRAX
Praxis Precision Medicines, Inc.NASDAQHealthcare$310.38-0.09%ClosedMarket Cap: $6.56B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
7.95
P/S
0.00
EV/EBITDA
-19.77
DCF Value
$14.95
FCF Yield
-3.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-58.7%
ROA
-32.3%
ROIC
-37.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-97.0M | $-88.9M | $-3.50 | — |
| FY 2025 | $0.00 | -Infinity% | $-326.2M | $-303.3M | $-13.48 | — |
| Q3 2025 | $0.00 | -Infinity% | $-78.4M | $-73.9M | $-3.36 | — |
| Q2 2025 | $0.00 | -Infinity% | $-76.1M | $-71.1M | $-3.31 | — |
| Q1 2025 | $0.00 | -Infinity% | $-74.7M | $-69.3M | $-3.29 | — |
| Q4 2024 | $7.5M | -654.2% | $-64.0M | $-58.7M | $-2.94 | — |
| FY 2024 | $8.6M | -1682.0% | $-200.2M | $-182.8M | $-10.21 | — |
| Q3 2024 | $302.0K | -13767.9% | $-56.8M | $-51.9M | $-2.75 | — |
| Q2 2024 | $357.0K | -7535.9% | $-37.5M | $-32.7M | $-1.74 | — |
| Q1 2024 | $431.0K | -6160.8% | $-41.9M | $-39.6M | $-2.84 | — |
| Q4 2023 | $515.0K | -3470.5% | $-27.8M | $-26.9M | $-2.97 | — |
| FY 2023 | $2.4M | -3445.8% | $-126.4M | $-123.3M | $-18.69 | — |